Ophthalmology Times - Ophthalmology news, articles, and events
WEBEyeCon 2024: Key takeaways for enhanced patient care from Day 1. This Week in Ophthalmology: Week of September 22, 2024. EyeCon 2024: Peter McDonnell, MD, and Laura Periman, MD, on the importance of integrating new knowledge into practice. Eyecon 2024: Thyroid Eye Disease in focus. Retina Society 2024: A …
Physicians sort out pros and cons of several new IOLs on the market
WEBNov 12, 2021 · Multifocal IOLs The 2 newest multifocal IOLs—AcrySof IQ PanOptix (Alcon) and Tecnis Synergy (Johnson + Johnson Vision)—almost guarantee a broader range of vision than EDoF IOLs but not the avoidance of photic phenomena, Sood said. The PanOptix is a trifocal lens with negative spherical aberration on …
Study suggests potential link between semaglutide and risk of non ...
WEBJul 9, 2024 · Boston researchers led by first author Jimena Tatiana Hathaway, MD, MPH, reported that there is a potential risk of the development of non-arteritic ischemic optic neuropathy (NAION) 1 associated with prescriptions for semaglutide (Wegovy, Ozempic, Novo Nordisk). Prescriptions with semaglutide are FDA approved to treat obesity and type 2 diabetes, respectively.
Myths and misconceptions about autologous serum for dry eye
WEBJun 22, 2020 · Special to Ophthalmology Times® Autologous serum eye drops (ASEDs) have become a mainstay of therapy for certain categories of patients with dry eye and those with underlying immunologic disease or poor epithelial healing.. The logistics of prescribing ASEDs have changed dramatically in the past few years, making their use far more convenient for patients and physicians alike.
FDA approves eye drops for treatment of presbyopia
WEBOct 30, 2021 · Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia. Allergan, an AbbVie company, announced FDA approval of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. According to the company, pilocarpine HCl ...
Oyster Point Pharma reports FDA approval of TYRVAYA nasal …
WEBOct 18, 2021 · Oyster Point Pharma, Inc. announced Monday that the U.S. Food and Drug Administration (FDA) has granted approval of its TYRVAYA TM (varenicline solution) nasal spray 0.03 mg for the treatment of dry eye disease (DED).. As the first — and currently only — nasal spray approved for DED treatment in the U.S., TYRVAYA TM is a highly-selective cholinergic agonist administered twice a day as an ...
IPL + thermal pulsation: A thorough approach to dry eye
WEBNov 6, 2018 · This one-two punch approach is logical: IPL treats inflammation, the underlying cause of dry eye disease. Thermal pulsation addresses meibomian gland dysfunction (MGD), a major component of dry eye pathology, by unclogging the glands and evacuating their abnormal content. When we treat both the inflammatory source and the resulting clogged ...
Long-term effects of COVID-19 on the ocular surface
WEBAug 16, 2024 · A team of Turkish investigators lead by Oğuzhan Kılıçarslan, FEBO, FICO, MD, reported that COVID-19 affected thecorneal endothelial cell morphology in patients with ocular symptoms. 1 Kılıçarslan is from the Department of Ophthalmology, Ayancık State Hospital, Sinop, Turkey. They conducted a study in which they investigated the long-term effects of the virus on corneal endothelial cell ...
Minimize inflammation after cataract surgery - Ophthalmology …
WEBOct 15, 2020 · Initiating topical treatment 3 days preoperatively also conferred no advantage for better inflammation control, whereas a dropless approach using a sub-Tenon corticosteroid injection proved inferior to topical treatment. “Controlling postoperative inflammation is important for achieving a successful outcome after cataract surgery.
Breaking down the dorzolamide shortage - Ophthalmology Times
WEBAug 9, 2019 · Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in …